[241230]相较于NSAID和csD, TNFi显著降低axSpA髋和脊柱的骨折风险

该研究最早展示于ACR2024年会, 目前已提前在线发表于ACR官刊A&R

Driscoll D, et al. Association of Therapies for Axial Spondyloarthritis on the Risk of Hip and Spine Fractures. Arthritis Rheumatol. 2024 Dec 16.